National statistics

PHE MRSA, MSSA, Gram-negative bacteraemia and CDI: quarterly report

Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.

Documents

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2021)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to January to March 2021)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2020

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, July to September 2020

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to April to June 2020)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to April to June 2020)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2020

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2020)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to January to March 2020)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2020

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to October to December 2019)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to October to December 2019)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2019

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to July to September 2019)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to July to September 2019)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, July to September 2019

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to April to June 2019)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to April to June 2019)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2019

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2019)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to January to March 2019)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2019

Details

From September 2017

The commentaries contain national aggregated data and an overview of the trends in the mandatory reports of HCAI; meticillin resistant Staphylococcus aureus (MRSA), meticillin susceptible Staphylococcus aureus (MSSA) and Gram-negative bacteraemia and Clostridioides difficile (C. difficile) infection, over recent quarters.

For previous quarterly commentaries and associated data please see:

Older quarterly commentaries and associated data are also available from the UK Government Web Archive.

Published 12 June 2014
Last updated 8 July 2021 + show all updates
  1. Added January to March 2021 quarterly epidemiological commentary and accompanying data.

  2. Added October to December 2020 quarterly epidemiological commentary and accompanying data.

  3. Added commentary and accompanying data spreadsheet for July to September 2020.

  4. Added commentary and accompanying data spreadsheet for April to June 2020.

  5. Added commentary and accompanying data spreadsheet for January to March 2020.

  6. Added commentary and accompanying data spreadsheet, for October to December 2019.

  7. Added commentary and accompanying data spreadsheet, for quarter July to September 2019.

  8. Added commentary and accompanying data spreadsheet, for April to June 2019; archived quarterly commentaries from June 2018 to March 2019.

  9. Added amended commentary for quarter January to March 2019 due to a data mismatch in figure 2.

  10. Added commentary and accompanying data spreadsheet, for quarter January to March 2019.

  11. Added commentary and accompanying data spreadsheet, for quarter October to December 2018.

  12. Added commentary and accompanying data spreadsheet, for quarter July to September 2018.

  13. Added commentary and accompanying data spreadsheet, for quarter April to June 2018; archived quarterly commentaries from June 2017 to March 2018.

  14. Added amended commentary and accompanying data spreadsheet, for quarter January to March 2018; due to corrected CDI data for quarter 3 financial year April 2007 to March 2008.

  15. Added commentary and accompanying data spreadsheet, for quarter January to March 2018; archived quarterly commentaries from 2013 to 2016.

  16. Added commentary and accompanying data spreadsheet for October to December 2017.

  17. Quarterly epidemiological commentary (up to July to September 2017).

  18. Added commentary and accompanying data spreadsheet, for quarter April to June 2017.

  19. Added commentary and accompanying data spreadsheet, for quarter January to March 2017.

  20. Added commentary and accompanying data spreadsheet, for quarter October to December 2016.

  21. Added commentary and accompanying data spreadsheet, for quarter July to September 2016.

  22. Added commentary and accompanying data spreadsheet, for quarter April to June 2016.

  23. Added commentary and accompanying data spreadsheet, for quarter January to March 2016.

  24. Added commentary for data, for quarter October to December 2015.

  25. Added commentary for data, July to September 2015.

  26. Added commentary for data, April to June 2015.

  27. Added commentary for data up to January to March 2015.

  28. Added commentary for data up to October to December 2014.

  29. Added commentary for data up to July to September 2014.

  30. Added commentary for data up to April to June 2014.

  31. First published.